The aim of topical antimicrobial treatment is to control microbial colonization and their consequent proliferation. Today, silver sulfadiazine is the most widely used topical antimicrobial for burn treatment. Silver sulfadiazine has numerous clinical advantages, including a broad antimicrobial spectrum and low toxicity. Silver sulfadiazine has in vitro activity against many burn wound pathogens including Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Klebsiella, Proterus, Enterobacteriaceae and Candida albicans. The frequency of resistance development with silver sulfadiazine is considerably lower than with other antimicrobials. So in the majority of burn patients the drug of preference for prophylaxis is silver sulfadiazine
The aim of topical antimicrobial treatment is to control microbial colonization and their consequent proliferation. Today, silver sulfadiazine is the most widely used topical antimicrobial for burn treatment. Silver sulfadiazine has numerous clinical advantages, including a broad antimicrobial spectrum and low toxicity. Silver sulfadiazine has in vitro activity against many burn wound pathogens including Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Klebsiella, Proterus, Enterobacteriaceae and Candida albicans. The frequency of resistance development with silver sulfadiazine is considerably lower than with other antimicrobials. So in the majority of burn patients the drug of preference for prophylaxis is silver sulfadiazine